DK1293196T3 - Farmaceutisk præparat der omfatter doxazosin - Google Patents

Farmaceutisk præparat der omfatter doxazosin

Info

Publication number: DK1293196T3
Authority: DK; Denmark
Prior art keywords: doxazosin; pharmaceutical composition; core; composition; hydrohilic
Prior art date: 2001-09-14

Application number

DK02291474T

Other languages

Danish (da)

English (en)

Inventor

Pawan Seth

Original Assignee

Cimex Pharma Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-09-14

Filing date

2002-06-13

Publication date

2006-07-17

2002-06-13 Application filed by Cimex Pharma Ag filed Critical Cimex Pharma Ag

2006-07-17 Application granted granted Critical

2006-07-17 Publication of DK1293196T3 publication Critical patent/DK1293196T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK02291474T 2001-09-14 2002-06-13 Farmaceutisk præparat der omfatter doxazosin DK1293196T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US09/953,072 US20030059467A1 (en)	2001-09-14	2001-09-14	Pharmaceutical composition comprising doxasozin

Publications (1)

Publication Number	Publication Date
DK1293196T3 true DK1293196T3 (da)	2006-07-17

Family

ID=25493537

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK02291474T DK1293196T3 (da)	2001-09-14	2002-06-13	Farmaceutisk præparat der omfatter doxazosin

Country Status (8)

Country	Link
US (1)	US20030059467A1 (pt)
EP (1)	EP1293196B1 (pt)
AT (1)	ATE321537T1 (pt)
CY (1)	CY1106084T1 (pt)
DE (1)	DE60212734T2 (pt)
DK (1)	DK1293196T3 (pt)
ES (1)	ES2259698T3 (pt)
PT (1)	PT1293196E (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7776314B2 (en)	2002-06-17	2010-08-17	Grunenthal Gmbh	Abuse-proofed dosage system
US20040162320A1 (en) *	2003-02-14	2004-08-19	Pawan Seth	Solid composition containing nisoldipine a mixture of polyethylene oxides and an antioxidant
CN100391459C (zh) *	2003-05-26	2008-06-04	沈阳药科大学	甲磺酸多沙唑嗪缓释制剂
US20070048228A1 (en)	2003-08-06	2007-03-01	Elisabeth Arkenau-Maric	Abuse-proofed dosage form
DE10361596A1 (de)	2003-12-24	2005-09-29	Grünenthal GmbH	Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
US8075872B2 (en)	2003-08-06	2011-12-13	Gruenenthal Gmbh	Abuse-proofed dosage form
DE10336400A1 (de)	2003-08-06	2005-03-24	Grünenthal GmbH	Gegen Missbrauch gesicherte Darreichungsform
DE102005005446A1 (de)	2005-02-04	2006-08-10	Grünenthal GmbH	Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE102004032051A1 (de)	2004-07-01	2006-01-19	Grünenthal GmbH	Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
WO2005037247A2 (en) *	2003-10-17	2005-04-28	Ranbaxy Laboratories Limited	Oral matrix formulations of doxazosin
DE102004032049A1 (de)	2004-07-01	2006-01-19	Grünenthal GmbH	Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de)	2005-02-04	2006-08-10	Grünenthal GmbH	Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
KR101366764B1 (ko) *	2005-05-31	2014-02-25	주식회사 씨티씨바이오	메실산독사조신 서방정의 제조방법
DE102007011485A1 (de)	2007-03-07	2008-09-11	Grünenthal GmbH	Darreichungsform mit erschwertem Missbrauch
BRPI0906467C1 (pt)	2008-01-25	2021-05-25	Gruenenthal Gmbh	forma de dosagem farmacêutica com formato exterior modificado resistente à ruptura e com liberação controlada
CN102123701B (zh)	2008-05-09	2013-03-27	格吕伦塔尔有限公司	使用喷雾冻凝步骤制备中间粉末制剂以及最终固体剂型的方法
HUE042987T2 (hu)	2009-07-22	2019-07-29	Gruenenthal Gmbh	Visszaéléssel szemben ellenálló adagolási forma oxidációra érzékeny opioidok számára
BR112012001547A2 (pt)	2009-07-22	2016-03-08	Gruenenthal Gmbh	forma de dosagem farmacêutica extrusada por fusão a quente
EP2611425B1 (en)	2010-09-02	2014-07-02	Grünenthal GmbH	Tamper resistant dosage form comprising an anionic polymer
ES2486791T3 (es)	2010-09-02	2014-08-19	Grünenthal GmbH	Forma de dosificación resistente a la manipulación que comprende una sal inorgánica
CN102058555A (zh) *	2011-01-13	2011-05-18	北京汇诚瑞祥医药技术有限公司	一种多沙唑嗪控释片
US10201502B2 (en)	2011-07-29	2019-02-12	Gruenenthal Gmbh	Tamper-resistant tablet providing immediate drug release
JP6063462B2 (ja)	2011-07-29	2017-01-18	グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング	即時薬剤放出を提供するタンパーレジスタント錠剤
AU2013225106B2 (en)	2012-02-28	2017-11-02	Grunenthal Gmbh	Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
CA2868142A1 (en)	2012-04-18	2013-10-24	Grunenthal Gmbh	Tamper resistant and dose-dumping resistant pharmaceutical dosage form
US10064945B2 (en)	2012-05-11	2018-09-04	Gruenenthal Gmbh	Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
US9737490B2 (en)	2013-05-29	2017-08-22	Grünenthal GmbH	Tamper resistant dosage form with bimodal release profile
EP3003279A1 (en)	2013-05-29	2016-04-13	Grünenthal GmbH	Tamper-resistant dosage form containing one or more particles
US10624862B2 (en)	2013-07-12	2020-04-21	Grünenthal GmbH	Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
AU2014356581C1 (en)	2013-11-26	2020-05-28	Grunenthal Gmbh	Preparation of a powdery pharmaceutical composition by means of cryo-milling
WO2015173195A1 (en)	2014-05-12	2015-11-19	Grünenthal GmbH	Tamper resistant immediate release capsule formulation comprising tapentadol
CN104224756A (zh) *	2014-09-26	2014-12-24	天津市聚星康华医药科技有限公司	一种甲磺酸多沙唑嗪口腔速溶膜及其制备方法
US20160310429A1 (en)	2015-04-24	2016-10-27	Grünenthal GmbH	Tamper-resistant dosage form with immediate release and resistance against solvent extraction
EP3346991A1 (en)	2015-09-10	2018-07-18	Grünenthal GmbH	Protecting oral overdose with abuse deterrent immediate release formulations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4765989A (en) *	1983-05-11	1988-08-23	Alza Corporation	Osmotic device for administering certain drugs
GB9523752D0 (en) *	1995-11-21	1996-01-24	Pfizer Ltd	Pharmaceutical formulations

2001
- 2001-09-14 US US09/953,072 patent/US20030059467A1/en not_active Abandoned
2002
- 2002-06-13 EP EP02291474A patent/EP1293196B1/en not_active Expired - Lifetime
- 2002-06-13 ES ES02291474T patent/ES2259698T3/es not_active Expired - Lifetime
- 2002-06-13 DE DE60212734T patent/DE60212734T2/de not_active Expired - Lifetime
- 2002-06-13 DK DK02291474T patent/DK1293196T3/da active
- 2002-06-13 AT AT02291474T patent/ATE321537T1/de active
- 2002-06-13 PT PT02291474T patent/PT1293196E/pt unknown
2006
- 2006-04-13 CY CY20061100512T patent/CY1106084T1/el unknown

Also Published As

Publication number	Publication date
EP1293196A2 (en)	2003-03-19
ES2259698T3 (es)	2006-10-16
DE60212734T2 (de)	2006-11-09
EP1293196B1 (en)	2006-03-29
PT1293196E (pt)	2006-05-31
EP1293196A3 (en)	2004-01-02
CY1106084T1 (el)	2011-06-08
DE60212734D1 (de)	2006-08-03
ATE321537T1 (de)	2006-04-15
US20030059467A1 (en)	2003-03-27

Similar Documents

Publication	Publication Date	Title
DK1293196T3 (da)	2006-07-17	Farmaceutisk præparat der omfatter doxazosin
DE50202328D1 (de)	2005-03-31	Amidofunktionelle aminopolydiorganosiloxane
MA26129A1 (fr)	2004-04-01	Melange insecticide contenant de la gamma-cyhalothrine
CL2008000762A1 (es)	2008-07-04	Compuestos derivados de pirimidinas; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento de la psoriasis, diabetes, artritis reumatoide, entre otras enfermedades ( divisional solicitud 1147-02).
IL201754A0 (en)	2010-06-16	Substituted 3,4-diamino cyclobutene-1,2- diones as cxc-chemokine receptor ligands and pharmaceutical compositions comprising the same
NO324227B1 (no)	2007-09-10	Cyclopropyl-kondenserte pyrrolidin-baserte forbindelser, farmasoytiske blandinger og kombinasjoner inneholdende slike samt anvendelse av slike for fremstilling av medikamenter for behandling av sykdommer
MY148680A (en)	2013-05-31	Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
IL168784A (en)	2010-12-30	Fused 1,3-dihydroimidazole ring compounds and pharmaceutical compositions comprising the same
DE60209929D1 (de)	2006-05-11	Succinate des 5,8,14-triazatetracycloä10.3.1.0 2,11 .0 4,9 ü-hexadeca-2(11),3,5,7,9,-pentaens und pharmazeutische zusammensetzungen
EE200300537A (et)	2004-04-15	Meetod madalaannuselise farmatseutilise kompositsiooni tootmiseks
MXPA03010158A (es)	2004-03-10	Sulfonamidas.
MXPA03007635A (es)	2003-12-04	P-tienilbencilamidas que sirven como agonistas de receptores para angiotensina-(1-7), metodo para su produccion, su uso y preparaciones farmaceuticas que las contienen.
SE0200657D0 (sv)	2002-03-04	Novel Formulation
HUP0303469A3 (en)	2004-04-28	Phtalazinon-derivatives, their use and pharmaceutical compositions containing them
HUP0401644A3 (en)	2008-03-28	Aminobenzoephenones, pharmaceutical compositions containing them and use thereof
MXPA04004090A (es)	2004-07-08	Compuestos substituidos de 1h-quinolin-2-ona.
EA200400343A1 (ru)	2004-08-26	Композиция с контролируемым высвобождением кларитромицина или тинидазола
HRPK20030766B3 (en)	2006-11-30	Combination of a taxane and cyclin-dependent kinase inhibitor
DE60206940D1 (de)	2005-12-01	Pektin und ascorbinsäure enthaltende zusammensetzungen
AU2002254930A1 (en)	2002-10-03	Novel medicament compositions based on anticholinergic agents and endothelin antagonists
CY1110737T1 (el)	2015-06-10	Υποκατεστημενες ενωσεις 1,5-διαμινοπενταν-3-ολης
NO20033073D0 (no)	2003-07-04	Farmasöytisk sammensetning inneholdende citalopram
GEP20084546B (en)	2008-11-25	Novel association consisting of an anti-atherothrombotic agent and of platelet antiaggregating agent
RU2001109481A (ru)	2003-08-10	Антиангинальное средство
MXPA04004262A (es)	2004-07-08	Delta-1-pirrolinas.